InvestorsHub Logo

Talon38

02/20/18 12:34 AM

#141752 RE: whippinsaw #141717

Whip, I think all of the Aducanumab trial participants are pre-Alzheimers and I assume healthy. However. since science has not bin able to exactly determine the cause of AD, I'm not sure what Biogen is using as a marker except maybe an abnormal level of amyloid plaque. I'll check Clinical Trials. gov and see if it has been updated with the 510 new participants.